Moving discovery to development, the Genopole ecosystem ensures fluidity between research, clinical trials, valorization and industrial development. To carry out its mission, Genopole pilots a program of actions and services comprising strong support to academic research teams, constant enrichment of the shareduse technological platforms, a Booster program to consolidate the growth of start-ups, a team of project managers to provide entrepreneurial guidance, the organization of events to share information and exchange ideas, and much more. In a tumultuous year, Genopole adapted its accompaniment strategy and reaffirmed its role as a catalyzer. New companies set up shop at the biocluster, which was able to count on the Île-de-France Administrative Region to favor its industrialization.


The Booster: from innovation to the creation of value

As the logical follow-up to the Shaker, the Booster program welcomes, among others, innovations that have bloomed in the Biotech Lab and become high-potential start-ups. Indeed, of the 33 companies selected for the Booster since its creation, 10 came from the Shaker. The others, created in the region, in France or elsewhere in the world, find in the Booster and the Genopole ecosystem human resources, the OpenLab, a coworking space and the technological tools they need to pursue their R&D.

Intended specifically for biotechs working in Genopole’s strategic sectors, the Booster synergizes with the biocluster’s foundation mission; in so doing, it provides a differentiating added value compared to other start-up accompaniment programs.
In 2020, the sixth and seventh Booster editions brought abord nine start-ups with great development potential. The program’s objective is to conduct the start-ups toward their first successful fund-raising campaign. The one-year Booster program puts entrepreneurs in contact with biotech creation experts. High level training (business model strategies, market access, fund raising, marketing, communications/ pitches, contractual/regulatory issues), provided online for the five laureates of the seventh edition, enables the adjustment of business strategies, market positioning, company communications, etc.
Other strengths of the Booster program include the longterm, custom-tailored accompaniment provided by Genopole project managers, the mutual aid among the laureates and the opportunity to establish relationships with Genopole’s network of investors.

Since its creation, 16 of the 33 Booster-accompanied start-ups have raised €10.4 million, 24 have benefitted from €7.5 million in public aid and loans, and 109 jobs have been created. Those numbers validate the Booster’s acceleration strategy and its ability to accompany startups in the economic valorization of their innovations.



Three programs to support research

Genopole launches several calls for candidates every year to strengthen the biocluster’s laboratories and businesses in both human resources and scientific competencies.

  • The postdoctoral allocations provide two years of salary for young researchers so that they can carry out research projects within a biocluster lab or business. Year 2020 saw the 91st and 92nd allocation recipients, the first of whom is working at the IBISC laboratory on the emerging field of network informatics and its use in the study of diseases, and the second at SABNP on gene splicing, a biological process that is vital for gene expression but also, when dysfunctional, a potential cause of genetic diseases and cancers. All of the postdoctoral allocation beneficiaries in the program’s 20-year history went on to find permanent positions in public or private research.
  • The Masters 2 grants are aimed at supporting student training in research and helping labs deploy new projects by funding six months of internship compensation. Five were awarded in 2020 in the fields of synthetic biology, genomics, bioinformatics in medical imaging and structural biology.
  • Genopole also financed high-level international training for three PhD students to enable their acquisition of interdisciplinary competencies (chemistry/biology/bioinformatics in 2020) that are both beneficial for their doctorate research and transferable to their teams.